Application of the WHO fracture risk assessment tool (FRAX) to predict need for DEXA scanning and treatment in patients with inflammatory bowel disease at risk of osteoporosis
- 作者J. R. Goodhand; N. Kamperidis; H. Nguyen; M. Wahed; D. S. Rampton
- 卷第33卷
- 期第5期
- 印刷ISSN0269-2813
- 电子ISSN1365-2036
- 文件大小247.38KB
- 发表时间2011
- DOI10.1111/j.1365-2036.2010.04554.x
- 页码551-558
The challenge of acute rejection in intestinal transplantationE. Y. Yoshitoshi, A. Yoshizawa, E. Ogawa, M. Kaneshiro, N. Takada, S. Okamoto, Y. Fujimoto, S. Sakamoto, S. Masuda, M. Matsuura, Y. Nakase, T. Chiba, T. Tsuruyama, H. Haga, S. Uemoto · 2012
Tacrolimus: rescue therapy or experimental drug for severe ulcerative colitis?H. Nakase; S. Yamamoto; M. Matsuura; T. Chiba · 2011
Long-term effect of tacrolimus therapy in patients with refractory ulcerative colitisS. YAMAMOTO; H. NAKASE; S. MIKAMI; S. INOUE; T. YOSHINO; Y. TAKEDA; K. KASAHARA; S. UENO; N. UZA; H. KITAMURA; H. TAMAKI; M. MATSUURA; K. INUI; T. CHIBA · 2008
Cytomegalovirus affects clinical outcome of infliximab in ulcerative colitis refractory to tacrolimusH. Nakase; S. Yamamoto; M. Matsuura; Y. Honzawa; T. Chiba · 2010
The effect of proteasome inhibitor MG132 on experimental inflammatory bowel diseaseS. Inoue; H. Nakase; M. Matsuura; S. Mikami; S. Ueno; N. Uza; T. Chiba · 2009
Tacrolimus suppresses IL-12/IL23 p40 in Crohn’s disease and heals fistulae refractory to anti-TNF-α therapyH. Nakase; M. Matsuura; N. Uza; T. Chiba · 2011